Target intelligence / Profile preview

Membrane phospholipids and lipid radicals

Molecular classification
Lipid, Reactive oxygen species (ROS) intermediate
01

Overview

Membrane phospholipids, particularly those containing polyunsaturated fatty acids (PUFAs) such as arachidonic acid, are critical structural components of cellular and organelle membranes. Under conditions of oxidative stress or iron-dependent catalysis, these lipids undergo peroxidation, leading to the formation of highly reactive lipid radicals (e.g., peroxyl and alkoxyl radicals). This biochemical cascade is the execution mechanism of ferroptosis, a form of regulated cell death characterized by the catastrophic collapse of membrane integrity. Therapeutic intervention focuses on the use of radical-trapping antioxidants (RTAs) that neutralize these lipid radicals to halt the chain reaction of lipid peroxidation. This target is of significant interest in treating neurodegenerative diseases, ischemia-reperfusion injury, and organ failure, as well as in oncology, where inducing lipid peroxidation can be used to kill therapy-resistant cancer cells.

Other names
Membrane lipidsPolyunsaturated fatty acids (PUFAs)Lipid peroxidesLipid hydroperoxidesLipid peroxyl radicalsLipid alkoxyl radicals
02

Mechanism of action

Radical-trapping antioxidants (RTAs) act by donating a hydrogen atom to lipid peroxyl radicals, thereby terminating the self-propagating chain reaction of lipid peroxidation and preventing membrane damage.

03

Biological functions

Membrane structural integrityCell signalingFerroptosis regulationOxidative stress responseIon permeability regulation
04

Disease associations

Neurodegenerative diseaseIschemia-reperfusion injuryCancerInflammationAcute kidney injuryCardiovascular disease
05

Safety considerations

Interference with physiological redox signalingPotential for pro-oxidant effects under specific conditionsSystemic antioxidant depletionPoor metabolic stability of certain radical-trapping agents
06

Interacting drugs

Ferrostatin-1

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)C11-BODIPY (581/591) oxidation8-IsoprostanePhospholipid hydroperoxides (PLOOH)

Beyond the preview

Go deeper on Membrane phospholipids and lipid radicals.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane phospholipids and lipid radicals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call